Skip to main content

Table 1 Prevalence in Burkina-Faso

From: The use of a P. falciparum specific coiled-coil domain to construct a self-assembling protein nanoparticle vaccine to prevent malaria

Antigen

Mean OD

% positive donors

SAPN-Combo

0.62

66

Pept-P27-NC*

0.43

62

Pept-P27-C*

0.22

62

  1. Sera of 48 donors leaving in Burkina-Faso were tested in ELISA at serum dilution of 1:200